JP2021512869A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021512869A5 JP2021512869A5 JP2020541731A JP2020541731A JP2021512869A5 JP 2021512869 A5 JP2021512869 A5 JP 2021512869A5 JP 2020541731 A JP2020541731 A JP 2020541731A JP 2020541731 A JP2020541731 A JP 2020541731A JP 2021512869 A5 JP2021512869 A5 JP 2021512869A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sodium
- amount
- total weight
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 33
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 7
- 239000000651 prodrug Substances 0.000 claims 7
- 229940002612 prodrug Drugs 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 5
- 239000003085 diluting agent Substances 0.000 claims 5
- 239000000314 lubricant Substances 0.000 claims 5
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 4
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 229920002472 Starch Polymers 0.000 claims 4
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 229940049654 glyceryl behenate Drugs 0.000 claims 4
- 239000008101 lactose Substances 0.000 claims 4
- 235000019359 magnesium stearate Nutrition 0.000 claims 4
- 229920000609 methyl cellulose Polymers 0.000 claims 4
- 239000001923 methylcellulose Substances 0.000 claims 4
- 235000010981 methylcellulose Nutrition 0.000 claims 4
- 229960002900 methylcellulose Drugs 0.000 claims 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- 229940032147 starch Drugs 0.000 claims 4
- 239000008107 starch Substances 0.000 claims 4
- 235000019698 starch Nutrition 0.000 claims 4
- 244000215068 Acacia senegal Species 0.000 claims 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 3
- 229920002261 Corn starch Polymers 0.000 claims 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 3
- 108010010803 Gelatin Proteins 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 3
- 229920000084 Gum arabic Polymers 0.000 claims 3
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims 3
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims 3
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims 3
- 235000021355 Stearic acid Nutrition 0.000 claims 3
- 235000010489 acacia gum Nutrition 0.000 claims 3
- 239000000205 acacia gum Substances 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000011230 binding agent Substances 0.000 claims 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 3
- 235000013539 calcium stearate Nutrition 0.000 claims 3
- 239000008116 calcium stearate Substances 0.000 claims 3
- 235000013868 candelilla wax Nutrition 0.000 claims 3
- 239000004204 candelilla wax Substances 0.000 claims 3
- 229940073532 candelilla wax Drugs 0.000 claims 3
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims 3
- 235000013869 carnauba wax Nutrition 0.000 claims 3
- 239000004203 carnauba wax Substances 0.000 claims 3
- 229940082483 carnauba wax Drugs 0.000 claims 3
- 239000008120 corn starch Substances 0.000 claims 3
- 229940099112 cornstarch Drugs 0.000 claims 3
- 239000007884 disintegrant Substances 0.000 claims 3
- 229910021485 fumed silica Inorganic materials 0.000 claims 3
- 229920000159 gelatin Polymers 0.000 claims 3
- 239000008273 gelatin Substances 0.000 claims 3
- 235000019322 gelatine Nutrition 0.000 claims 3
- 235000011852 gelatine desserts Nutrition 0.000 claims 3
- 239000008103 glucose Substances 0.000 claims 3
- 235000001727 glucose Nutrition 0.000 claims 3
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 3
- 239000008109 sodium starch glycolate Substances 0.000 claims 3
- 229940079832 sodium starch glycolate Drugs 0.000 claims 3
- 229920003109 sodium starch glycolate Polymers 0.000 claims 3
- 239000000600 sorbitol Substances 0.000 claims 3
- 239000008117 stearic acid Substances 0.000 claims 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 2
- 208000004051 Chronic Traumatic Encephalopathy Diseases 0.000 claims 2
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 208000008348 Post-Concussion Syndrome Diseases 0.000 claims 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 2
- 240000008042 Zea mays Species 0.000 claims 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 239000000783 alginic acid Substances 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 229960001126 alginic acid Drugs 0.000 claims 2
- 150000004781 alginic acids Chemical class 0.000 claims 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 2
- 235000010216 calcium carbonate Nutrition 0.000 claims 2
- 239000001110 calcium chloride Substances 0.000 claims 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims 2
- 239000001506 calcium phosphate Substances 0.000 claims 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 2
- 235000011010 calcium phosphates Nutrition 0.000 claims 2
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims 2
- 239000004359 castor oil Substances 0.000 claims 2
- 235000019438 castor oil Nutrition 0.000 claims 2
- 229960001777 castor oil Drugs 0.000 claims 2
- 229960004106 citric acid Drugs 0.000 claims 2
- 235000015165 citric acid Nutrition 0.000 claims 2
- 235000005822 corn Nutrition 0.000 claims 2
- 229960001681 croscarmellose sodium Drugs 0.000 claims 2
- 229960000913 crospovidone Drugs 0.000 claims 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 2
- 229960002433 cysteine Drugs 0.000 claims 2
- 208000017004 dementia pugilistica Diseases 0.000 claims 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims 2
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 claims 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims 2
- 229960003943 hypromellose Drugs 0.000 claims 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims 2
- 239000001095 magnesium carbonate Substances 0.000 claims 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims 2
- 239000000395 magnesium oxide Substances 0.000 claims 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 2
- 239000002480 mineral oil Substances 0.000 claims 2
- 235000010446 mineral oil Nutrition 0.000 claims 2
- 229940042472 mineral oil Drugs 0.000 claims 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims 2
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims 2
- 239000012188 paraffin wax Substances 0.000 claims 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 229940069328 povidone Drugs 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- 235000012239 silicon dioxide Nutrition 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 229940083542 sodium Drugs 0.000 claims 2
- 235000010413 sodium alginate Nutrition 0.000 claims 2
- 239000000661 sodium alginate Substances 0.000 claims 2
- 229940005550 sodium alginate Drugs 0.000 claims 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 2
- 235000010234 sodium benzoate Nutrition 0.000 claims 2
- 239000004299 sodium benzoate Substances 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 2
- 229940045902 sodium stearyl fumarate Drugs 0.000 claims 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- RAGZEDHHTPQLAI-UHFFFAOYSA-L disodium;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21 RAGZEDHHTPQLAI-UHFFFAOYSA-L 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 1
- 201000009941 intracranial hypertension Diseases 0.000 claims 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 claims 1
- 230000002018 overexpression Effects 0.000 claims 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 claims 1
- 235000010334 sodium propionate Nutrition 0.000 claims 1
- 239000004324 sodium propionate Substances 0.000 claims 1
- 229960003212 sodium propionate Drugs 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 102000013498 tau Proteins Human genes 0.000 claims 1
- 108010026424 tau Proteins Proteins 0.000 claims 1
- 0 Cc(cccc1)c1-c(cc(N1CCN(*)CC1)nc1)c1C(N(C)Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)=O Chemical compound Cc(cccc1)c1-c(cc(N1CCN(*)CC1)nc1)c1C(N(C)Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018900324A AU2018900324A0 (en) | 2018-02-02 | Oral Formulations and Uses Thereof | |
| AU2018900324 | 2018-02-02 | ||
| PCT/AU2019/050076 WO2019148247A1 (en) | 2018-02-02 | 2019-02-01 | Oral formulations and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512869A JP2021512869A (ja) | 2021-05-20 |
| JP2021512869A5 true JP2021512869A5 (enExample) | 2022-01-11 |
Family
ID=67477795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020541731A Pending JP2021512869A (ja) | 2018-02-02 | 2019-02-01 | 経口製剤及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200368166A1 (enExample) |
| EP (1) | EP3746078A4 (enExample) |
| JP (1) | JP2021512869A (enExample) |
| CN (1) | CN111670035A (enExample) |
| AU (1) | AU2019215802A1 (enExample) |
| CA (1) | CA3089656A1 (enExample) |
| MX (1) | MX2020008137A (enExample) |
| WO (1) | WO2019148247A1 (enExample) |
| ZA (1) | ZA202005143B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11801244B2 (en) | 2018-02-02 | 2023-10-31 | Eustralis Pharmaceuticals Limited | Parenteral formulations and uses thereof |
| AU2019414285B2 (en) | 2018-12-24 | 2024-11-14 | Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro) | Chemical compound manufacture, new salt form, and therapeutic uses thereof |
| WO2021035289A1 (en) * | 2019-08-23 | 2021-03-04 | Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro) | Therapeutic methods and uses thereof |
| CN118766972A (zh) * | 2020-09-30 | 2024-10-15 | 杭州远大生物制药有限公司 | 微生物制剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI367112B (en) * | 2006-06-30 | 2012-07-01 | Schering Corp | Immediate-release tablet formulations of a thrombin receptor antagonist |
| KR20100055430A (ko) * | 2007-07-19 | 2010-05-26 | 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 | 두개내압 감소 방법 |
| EP2217217B1 (en) * | 2007-11-23 | 2018-05-30 | Lupin Limited | Controlled release pharmaceutical compositions of pregabalin |
| PE20121483A1 (es) * | 2009-11-18 | 2012-12-02 | Helsinn Healthcare Sa | Composiciones para tratar nausea y vomito centralmente mediados |
| IN2013MU02031A (enExample) * | 2013-06-14 | 2015-06-05 | Novoexcipients Pvt Ltd | |
| JP6464421B2 (ja) * | 2013-07-02 | 2019-02-06 | ユーストラリス ファーマシューティカルズ リミテッド （トレーディング アズ プレススラ ニューロ） | 慢性外傷性脳障害ｉｉを予防及び／又は治療する方法 |
| CA2930199C (en) * | 2013-11-12 | 2022-10-25 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases |
| MX2016006742A (es) * | 2013-12-03 | 2016-08-12 | Hoffmann La Roche | Composicion farmaceutica. |
-
2019
- 2019-02-01 WO PCT/AU2019/050076 patent/WO2019148247A1/en not_active Ceased
- 2019-02-01 EP EP19747749.0A patent/EP3746078A4/en not_active Withdrawn
- 2019-02-01 MX MX2020008137A patent/MX2020008137A/es unknown
- 2019-02-01 US US16/966,289 patent/US20200368166A1/en not_active Abandoned
- 2019-02-01 AU AU2019215802A patent/AU2019215802A1/en not_active Abandoned
- 2019-02-01 CA CA3089656A patent/CA3089656A1/en active Pending
- 2019-02-01 JP JP2020541731A patent/JP2021512869A/ja active Pending
- 2019-02-01 CN CN201980011256.3A patent/CN111670035A/zh active Pending
-
2020
- 2020-08-19 ZA ZA2020/05143A patent/ZA202005143B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI583384B (zh) | 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物 | |
| JP2015091822A5 (enExample) | ||
| JP2021001196A5 (enExample) | ||
| JP2021512117A5 (enExample) | ||
| JP7023945B2 (ja) | レナリドミドの経口用錠剤組成物 | |
| JP2011500583A5 (enExample) | ||
| JP2016537347A5 (enExample) | ||
| JP2018507200A5 (enExample) | ||
| JP2009537538A5 (enExample) | ||
| JP7665702B2 (ja) | アキシチニブを含有する医薬組成物 | |
| JP2020511419A5 (enExample) | ||
| JP2019526591A5 (enExample) | ||
| JP2023536667A5 (enExample) | ||
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| WO2019142207A1 (en) | Pharmaceutical compositions comprising ibrutinib | |
| WO2012123922A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| JP2023551712A5 (enExample) | ||
| JP2023548855A5 (enExample) | ||
| WO2016079687A1 (en) | Oral pharmaceutical composition of teriflunomide | |
| JP7226697B2 (ja) | ブロナンセリン含有錠剤 | |
| JP2018145095A (ja) | エルロチニブ塩酸塩含有医薬組成物 | |
| WO2015069203A1 (en) | Capsule comprising rupatadine fumarate and montelukast sodium | |
| JP2015221782A (ja) | モンテルカストナトリウム含有製剤 | |
| WO2019171394A1 (en) | Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochloride | |
| CN104093400A (zh) | 稳定的无定形雷特格韦钾盐预混料及其制备方法 |